HC Wainwright & Co. Reiterates Buy on Alimera Sciences, Maintains $5 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Alimera Sciences (NASDAQ:ALIM) and maintained a $5 price target.
August 14, 2023 | 10:39 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alimera Sciences has received a reiterated 'Buy' rating from HC Wainwright & Co. with a maintained price target of $5.
The reiterated 'Buy' rating and maintained price target by HC Wainwright & Co. indicates their continued confidence in Alimera Sciences. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100